Cogentix Medical In (CGNT) Where Moving Ahead?

Man pointing to the tip of an upward sloping chart

Man pointing to the tip of an upward sloping chart

The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 100%.

In terms of earnings per share, 3 analysts have a -0.01 EPS mean target for the quarter ending Mar-18, for the quarter ending Jun-18, 3 analysts have a 0.00 EPS mean target and for the quarter ending Jun-18 there are 3 estimates of 0.00 EPS. According to these analysts, the Low Revenue Estimate for Cogentix Medical, Inc.is 15 Million and the High Revenue Estimate is 15.5 Million.

At the moment 3 analysts are watching Cogentix Medical, Inc.

Cogentix Medical In (NASDAQ:CGNT) shares traded 13.35% up during most recent session to reach at the closing price of $3.82.

Trump Asked Tillerson To Step Aside Before Talks With North Korea
Trump's Twitter announcement came only a few hours after Tillerson landed in Washington after the trip, which had been cut short. Tillerson continued to insist his relationship with the president was solid and brushed off rumors of strain between them.

Researchers identify over 500 genes related to intelligence
The study - the largest of its kind - could lead to new treatments for Alzheimer's disease. Some of these genes have already been linked to other things, such as longevity.

Siale Angilau Shot In Courtroom After Attacking Witness
As US District Judge Tena Campbell was escorted out of the courtroom, someone called 911 at the end of the released video. The family of Siale Angilau , 25, have argued that the United States marshal who shot him dead used excessive force.

Additionally on 11/08/17 Roth Capital "Reinstates" Cogentix Medical In (NASDAQ:CGNT) to Buy setting price target at $4 and on 10/06/17 JMP Securities "Initiates Coverage On" the stock to Outperform at $5. These analysts have also projected a High Estimate of $0.01/share.

The Relative Volume of the company is 60.44 and Average Volume (3 months) is 65.65 million. Analysts reported that the Price Target for Cogentix Medical, Inc. might touch $5 high while the Average Price Target and Low price Target is $4.58 and $4 respectively. For the quarter ending Jun-18, 3 analysts have a mean sales target of 15.93 million whilst for the year ending Dec-18, 3 analysts have a mean target of 64.47 million. This continues the company's recent uptrend - as the stock is now up 23.6% over past one month time frame.

Now insiders hold 30,819,372 shares in the business which makes up 50.60% of shares. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded 3.29%.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.